Cyproterone 50 mg (Cyproterone Acetate TABLET) 50 MG

Cyproterone acetate works by acting as a competitive antagonist of androgen receptors and exhibiting progestogenic activity. It suppresses gonadotropin secretion, reducing the production of testosterone, which is crucial for the growth of prostate cancer cells and other androgen-dependent conditions.

The usual dose of CYPROTERONE is determined by a healthcare provider based on the condition being treated and the patient's individual needs. It is typically taken in divided doses after meals, with the exact dosage and duration of treatment varying depending on the specific condition.

CYPROTERONE should be avoided during pregnancy due to the potential risk of feminisation of male foetuses. Women of childbearing potential should exclude pregnancy before starting treatment and use effective contraception during therapy.

To order CYPROTERONE from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then provide pricing, availability, shipping, and the necessary import paperwork.

CYPROTERONE is one of several antiandrogens available for treating androgen-dependent conditions. It is often compared to other antiandrogens like spironolactone and finasteride. The choice of medication depends on the specific condition, patient response, and potential side effects.

CYPROTERONE should be stored below 25°C, kept in the original pack, and protected from moisture. It is important to follow the storage instructions provided to maintain the medication's effectiveness and safety.

CYPROTERONE is administered orally in the form of tablets. The tablets should be taken as prescribed by a healthcare provider, typically in divided doses after meals. The exact dosage and duration of treatment will depend on the condition being treated.

The most serious risks associated with CYPROTERONE include liver toxicity, blood clots, severe depression or mood changes, allergic reactions, and changes in blood cell counts. Patients should be monitored regularly for these potential side effects.

CYPROTERONE should not be used by individuals with known allergies to cyproterone acetate or any of the inactive ingredients in the medication. It should also be avoided during pregnancy and in patients with severe liver disease. Always consult a healthcare provider before starting any new medication.